Novavax stock closes lower despite Q2 earnings beat

Novavax (NVAX) shares closed lower on Tuesday, despite the company reporting a surprise profit in the second quarter. The biotech company's results got a lift from Covid vaccine sales, but it was forced to cut its revenue guidance. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the report.